Viridian Therapeutics, Inc.\DE's top three insider shareholders as of May 04, 2026 are Funds Management Llc Fairmount (Director, 3.91Mn shares), Life Sciences Public Fund, L.P. Frazier (TenPercentOwner, 1.51Mn shares), Jonathan Violin (Chief Executive Officer, 480.90K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Funds Management Llc Fairmount | - | 0 | 3,914,458 | 27 Oct, 2025 |
| Life Sciences Public Fund, L.P. Frazier | - | 1,505,200 | 0 | 28 Sep, 2021 |
| Jonathan Violin | Chief Executive Officer | 480,905 | 0 | 07 Feb, 2023 |
| Scott Dunseth Myers | Chief Executive Officer | 259,500 | 0 | 12 Apr, 2023 |
| Stephen F. Mahoney | President And Ceo | 33,349 | 0 | 09 Mar, 2026 |
| Lara Meisner | Chief Legal Officer | 29,971 | 0 | 20 Jun, 2023 |
| Thomas W. Beetham | Chief Operating Officer | 13,361 | 0 | 09 Mar, 2026 |
| Seth Harmon | Chief Financial Officer | 7,850 | 0 | 09 Mar, 2026 |
| Jennifer Tousignant | Chief Legal Officer | 3,494 | 0 | 09 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Mar, 2026 | Stephen F. Mahoney | Common Stock | D | 7,408 | $30.19 | 33,349 | D | F |
| 03 Mar, 2026 | Jennifer Tousignant | Common Stock | D | 1,675 | $30.19 | 3,494 | D | F |
| 03 Mar, 2026 | Seth Harmon | Common Stock | D | 2,031 | $30.19 | 7,850 | D | F |
| 03 Mar, 2026 | Thomas W. Beetham | Common Stock | D | 3,048 | $30.19 | 13,361 | D | F |
| 03 Mar, 2026 | Seth Harmon | Common Stock | A | 6,267 | - | 9,881 | D | M |
| 03 Mar, 2026 | Thomas W. Beetham | Common Stock | A | 9,409 | - | 16,409 | D | M |
| 02 Mar, 2026 | Radhika Tripuraneni | Stock Option (Right to Buy) | A | 95,800 | $0.00 | 95,800 | D | A |
| 03 Mar, 2026 | Stephen F. Mahoney | Common Stock | A | 18,357 | - | 40,757 | D | M |
| 03 Mar, 2026 | Jennifer Tousignant | Common Stock | A | 5,169 | - | 5,169 | D | M |
| 03 Mar, 2026 | Seth Harmon | Common Stock | D | 2,091 | $29.32 | 7,790 | D | F |
| 03 Mar, 2026 | Stephen F. Mahoney | Common Stock | D | 7,627 | $29.32 | 33,130 | D | F |
| 02 Mar, 2026 | Radhika Tripuraneni | Restricted Stock Units | A | 19,150 | $0.00 | 19,150 | D | A |
| 03 Mar, 2026 | Jennifer Tousignant | Common Stock | D | 1,724 | $29.32 | 3,445 | D | F |
| 03 Mar, 2026 | Thomas W. Beetham | Common Stock | D | 3,138 | $29.32 | 13,271 | D | F |
| 02 Mar, 2026 | Seth Harmon | Stock Option (Right to Buy) | A | 102,850 | $0.00 | 102,850 | D | A |
| 02 Mar, 2026 | Thomas W. Beetham | Stock Option (Right to Buy) | A | 176,550 | $0.00 | 176,550 | D | A |
| 02 Mar, 2026 | Jennifer Tousignant | Stock Option (Right to Buy) | A | 119,300 | $0.00 | 119,300 | D | A |
| 02 Mar, 2026 | Stephen F. Mahoney | Stock Option (Right to Buy) | A | 559,600 | $0.00 | 559,600 | D | A |
| 02 Mar, 2026 | Seth Harmon | Restricted Stock Units | A | 20,550 | $0.00 | 20,550 | D | A |
| 02 Mar, 2026 | Thomas W. Beetham | Restricted Stock Units | A | 35,300 | $0.00 | 35,300 | D | A |